Table of Contents
Metal-Based Drugs
Volume 2008, Article ID 754358, 7 pages
http://dx.doi.org/10.1155/2008/754358
Research Article

Synthesis and Cytotoxicity Studies of Titanocene C Analogues

Conway Institute of Biomolecular and Biomedical Research, The UCD School of Chemistry and Chemical Biology, Centre for Synthesis and Chemical Biology (CSCB), University College Dublin, Belfield, Dublin 4, Ireland

Received 12 June 2007; Accepted 23 July 2007

Academic Editor: Jannie C. Swarts

Copyright © 2008 Megan Hogan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Schilling, K. B. Keppler, M. E. Heim et al., “Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane,” Investigational New Drugs, vol. 13, no. 4, pp. 327–332, 1995. View at Publisher · View at Google Scholar
  2. E. Meléndez, “Titanium complexes in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 309–315, 2002. View at Publisher · View at Google Scholar
  3. F. Caruso and M. Rossi, “Antitumor titanium compounds and related metallocenes,” Metal Ions in Biological Systems, vol. 42, pp. 353–384, 2004. View at Google Scholar
  4. G. Lümmen, H. Sperling, H. Luboldt, T. Otto, and H. Rübben, “Phase II trial of titanocene dichloride in advanced renal-cell carcinoma,” Cancer Chemotherapy and Pharmacology, vol. 42, no. 5, pp. 415–417, 1998. View at Publisher · View at Google Scholar
  5. N. Kröger, U. R. Kleeberg, K. Mross, L. Edler, G. Saß, and D. Hossfeld, “Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer,” Onkologie, vol. 23, no. 1, pp. 60–62, 2000. View at Google Scholar
  6. J. Eisch, X. Shi, and F. Owuor, “Novel synthesis of ansa-metallocenes via the reductive dimerization of fulvenes with group 4 metal divalent halides,” Organometallics, vol. 17, no. 24, pp. 5219–5221, 1998. View at Publisher · View at Google Scholar
  7. S. Fox, J. Dunne, M. Tacke, and J. F. Gallagher, “Novel derivatives of ansa-titanocenes procured from 6-phenylfulvene: a combined experimental and theoretical study,” Inorganica Chimica Acta, vol. 357, no. 1, pp. 225–234, 2004. View at Publisher · View at Google Scholar
  8. M. Tacke, L. Allen, L. Cuffe et al., “Novel titanocene anti-cancer drugs derived from fulvenes and titanium dichloride,” Journal of Organometallic Chemistry, vol. 689, no. 13, pp. 2242–2249, 2004. View at Publisher · View at Google Scholar
  9. F.-J. Rehmann, L. Cuffe, O. Mendoza et al., “Heteroaryl substituted ansa-titanocene anti-cancer drugs derived from fulvenes and titanium dichloride,” Applied Organometallic Chemistry, vol. 19, no. 3, pp. 293–300, 2005. View at Publisher · View at Google Scholar
  10. M. Tacke, L. Cuffe, W. Gallagher et al., “Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichloride,” Journal of Inorganic Biochemistry, vol. 98, no. 12, pp. 1987–1994, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. F.-J. Rehmann, A. Rous, O. Mendoza et al., “A trimethoxyphenyl substituted ansa-titanocene: a possible anti-cancer drug,” Polyhedron, vol. 24, no. 11, pp. 1250–1255, 2005. View at Publisher · View at Google Scholar
  12. N. Sweeney, O. Mendoza, H. Müller-Bunz et al., “Novel benzyl substituted titanocene anti-cancer drugs,” Journal of Organometallic Chemistry, vol. 690, no. 21-22, pp. 4537–4544, 2005. View at Publisher · View at Google Scholar
  13. C. Pampillón, O. Mendoza, N. Sweeney, K. Strohfeldt, and M. Tacke, “Diarylmethyl substituted titanocenes: promising anti-cancer drugs,” Polyhedron, vol. 25, no. 10, pp. 2101–2108, 2006. View at Publisher · View at Google Scholar
  14. C. Pampillón, N. Sweeney, K. Strohfeldt, and M. Tacke, “Diheteroarylmethyl substituted titanocenes: a novel class of possible anti-cancer drugs,” Inorganica Chimica Acta, vol. 359, no. 12, pp. 3969–3975, 2006. View at Publisher · View at Google Scholar
  15. N. Sweeney, W. M. Gallagher, H. Müller-Bunz, C. Pampillón, K. Strohfeldt, and M. Tacke, “Heteroaryl substituted titanocenes as potential anti-cancer drugs,” Journal of Inorganic Biochemistry, vol. 100, no. 9, pp. 1479–1486, 2006. View at Publisher · View at Google Scholar · View at PubMed
  16. K. Strohfeldt, H. Müller-Bunz, C. Pampillón, N. Sweeney, and M. Tacke, “Glycol methyl ether and glycol amine substituted titanocenes as antitumor agents,” European Journal of Inorganic Chemistry, vol. 2006, no. 22, pp. 4621–4628, 2006. View at Publisher · View at Google Scholar
  17. N. Sweeney, J. Claffey, H. Müller-Bunz, C. Pampillón, K. Strohfeldt, and M. Tacke, “The synthesis and cytotoxic evaluation of a series of benzodioxole substituted titanocenes,” Applied Organometallic Chemistry, vol. 21, no. 2, pp. 57–65, 2007. View at Publisher · View at Google Scholar
  18. O. Allen, L. Croll, A. Gott, R. Knox, and P. McGowan, “Functionalized cyclopentadienyl titanium organometallic compounds as new antitumor drugs,” Organometallics, vol. 23, no. 2, pp. 288–292, 2004. View at Publisher · View at Google Scholar
  19. P. Causey, M. Baird, and S. P. C. Cole, “Synthesis, characterization, and assessment of cytotoxic properties of a series of titanocene dichloride derivatives,” Organometallics, vol. 23, no. 19, pp. 4486–4494, 2004. View at Publisher · View at Google Scholar
  20. R. Meyer, S. Brink, C. van Rensburg, G. Jooné, H. Görls, and S. Lotz, “Synthesis, characterization and antitumor properties of titanocene derivatives with thiophene containing ligands,” Journal of Organometallic Chemistry, vol. 690, no. 1, pp. 117–125, 2005. View at Publisher · View at Google Scholar
  21. G. Kelter, N. Sweeney, K. Strohfeldt, H.-H. Fiebig, and M. Tacke, “In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes,” Anti-Cancer Drugs, vol. 16, no. 10, pp. 1091–1098, 2005. View at Publisher · View at Google Scholar
  22. O. Oberschmidt, A.-R. Hanauske, F.-J. Rehmann, K. Strohfeldt, N. Sweeney, and M. Tacke, “Activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride against tumor colony-forming units,” Anti-Cancer Drugs, vol. 16, no. 10, pp. 1071–1073, 2005. View at Publisher · View at Google Scholar
  23. K. O'Connor, C. Gill, M. Tacke et al., “Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells,” Apoptosis, vol. 11, no. 7, pp. 1205–1214, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. M. Valadares, A. Ramos, F.-J. Rehmann et al., “Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour,” European Journal of Pharmacology, vol. 534, no. 1–3, pp. 264–270, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. I. Fichtner, C. Pampillón, N. Sweeney, K. Strohfeldt, and M. Tacke, “Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice,” Anti-Cancer Drugs, vol. 17, no. 3, pp. 333–336, 2006. View at Publisher · View at Google Scholar
  26. C. Pampillón, N. Sweeney, K. Strohfeldt, and M. Tacke, “Synthesis and cytotoxicity studies of new dimethylamino-functionalised and heteroaryl-substituted titanocene anti-cancer drugs,” Journal of Organic Chemistry, vol. 692, no. 11, pp. 2153–2159, 2007. View at Publisher · View at Google Scholar
  27. T. Suzuka, M. Ogasawa, and T. Hayashi, “Asymmetric synthesis of metallocenes through enantioselective addition of organolithium reagents to 6-(dimethylamino)fulvene,” Journal of Organic Chemistry, vol. 67, no. 10, pp. 3355–3359, 2002. View at Publisher · View at Google Scholar
  28. Y. Qian, J. Huang, J. Yang et al., “Syntheses, structures and reactions of some new benzyl-substituted cyclopentadienyl titanium complexes,” Journal of Organometallic Chemistry, vol. 547, no. 2, pp. 263–279, 1997. View at Publisher · View at Google Scholar
  29. M. Horáček, P. Štěpnička, S. Gentil et al., “Syntheses and properties of some exo,exo-bis(isodicyclopentadienyl)titanium low-valent complexes,” Journal of Organometallic Chemistry, vol. 656, no. 1-2, pp. 81–88, 2002. View at Publisher · View at Google Scholar
  30. S. Knüppel, C. Wang, G. Kehr, R. Fröhlich, and G. Erker, “Bis(enamino-Cp) Group 4 metal complex chemistry: developing a Mannich-type carbon-carbon coupling reaction at the bent metallocene famework,” Journal of Organometallic Chemistry, vol. 690, no. 1, pp. 14–32, 2005. View at Publisher · View at Google Scholar
  31. Gaussian '03, Revision C.02, Gaussian, Wallingford, Conn, USA, 2004.